Anti-vector immunoglobulin induced by retroviral vectors

Human Gene Therapy

Volumn 8, Issue 10, 1997, Pages 1263-1273

  McCormack, James E ^a   Martineau, Darlene ^a   DePolo, Nicholas ^a   Maifert, Stephanie ^a   Akbarian, Leila ^a   Townsend, Kay ^a   Lee, Will ^a   Irwin, Mike ^a   Sajjadi, Nancy ^a   Jolly, Douglas J ^a   Warner, John ^a,b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Inex Pharmaceuticals Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; IMMUNE RESPONSE; IMMUNOTHERAPY; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIMATE; RETROVIRUS; VIRUS PARTICLE;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; PRIMATES; UNIDENTIFIED RETROVIRUS;

EID: 16944364983     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.10-1263     Document Type: Article

References (22)

1. ARTHUR, L.O., BESS, J.W., SOWDER, R.C., BENVENISTE, R.E., MANN, D.L., CHERMANN, J.-C., and HENDERSON, L.E. (1992). Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science 258, 1935-1938.
2. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient strains. Gene Ther. 2, 151-155.
3. COFFIN, I.M. (1990). Retroviridae and their replication. In Virology. B.N. Fields, D.M. Knipe, R.M. CHANOCK, M.S. HIRSCH, J.L. MELNICK, T.P. MONATH, and B. ROIZMAN, eds. (Raven Press, New York).
4. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
5. DONAHUE, R.E., KESSLER, S.W., BODINE, D., MCDONAGH, K., DUNBAR, C., GOODMAN, S., AGRICOLA, B., BYRNE, E., RAFFELD, M., MOEN, R., BACHER, J., ZSEBO, D.M., and NIENHUIS, A.W. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176, 1125-1135.
6. GALILI, U. (1993). Interaction of the natural anti-Gal antibody with Zα-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol. Today 14, 480-482.
7. IRWIN, M.J., LAUBE, L.S., LEE, V., AUSTIN, M., CHADA, S., ANDERSON, C.-G., TOWNSEND, K., JOLLY, D.J., and WARNER, J.F. (1994). Direct Injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J. Virol. 68, 5036-5044.
8. JOLLY, D. (1994). Viral vector systems for gene therapy. Cancer Gene Ther. 1, 51-64.
9. JOLLY, D.J., and WARNER, J.F. (1990). Retroviral vectors as vaccines and immunotherapeutics. Sem. Immunol. 2, 329-339.
10. KAPLAN, J.M., ST. GEORGE, J.A., PENNINGTON, S.E., KEYES, L.D., JOHNSON, R.P., WADSWORTH, S.C., and SMITH, A.E. (1996). Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3, 117-127.
11. KASS-EISLER, A., FALCK-PEDERSEN, E., ELFENBEIN, D.H., ALVIRA, M. BUTTRICK, P.M., and LEINWAND, L.A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1, 395-402.
12. KOZARSKY, K.F., MCKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
13. MARTINEAU, D., KLUMP, W.W., MCCORMACK, J.E., DEPOLO, N.J., KAMANTIGUE, E., PETROWSKI, M., HANLON, J., JOLLY, D.J., MENTO, S.J., and SAJJADI, N. (1997). Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication competent retroviruses. Hum. Gene Ther. 8, 1231-1241.
14. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2859-2902.
15. ROTH, J.A., NGUYEN, D., LAWRENCE, D.D., KEMP, B.L., CARRASCO, C.H., FERSON, D.Z., HONG, W.K., KOMAKI, R., LEE, J.J., NESBITT, J.C., PISTERS, K.M.W., PUTNAM, J.B., SCHEA, R., SHIN, D.M., WALSH, G.L., DOLORMENTE, M.M., HAN, C.-I., MARTIN, F.D., YEN, N., XU, K., STEPHENS, L.C., MCDONNELL, T.J., MUKHOPADHYAY, T., and CAI, D. (1996). Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med. 2, 985-991.
16. SUOMALAINEN, M., and GAROFF, H. (1994). Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 68, 4879-4889.
17. + T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. J. Virol. 71, 3365-3374.
18. WARNER, J.F., JOLLY, D., MENTO, S., GALPIN, J., HAUBRICH, R., and MERRITT, J. (1995). Retroviral vectors for HIV immunotherapy. Ann. N.Y. Acad. Sci. 772, 105-116.
19. WEISS, R., TEICH, N., VARMUS, H., and COFFIN, J. (1984). RNA Tumor Viruses - Molecular Biology of Tumor Viruses, 2nd ed. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
20. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
21. YEI, S., MITTEREDER, N., TANG, K., O'SULLIVAN, C., and TRAPNELL, B.C. (1994). Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1, 192-200.
22. IIIB Env/Rev proteins. AIDS 9, 43-50.